What is LOPJLB’s current signal on FENC?

LOPJLB’s latest quantitative signal on Fennec Pharmaceuticals Inc. (FENC) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is FENC in?

Fennec Pharmaceuticals Inc. (FENC) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Fennec Pharmaceuticals Inc. (FENC) do?

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under th…

Where is Fennec Pharmaceuticals Inc. based / listed?

Fennec Pharmaceuticals Inc. is based in US, listed on NASDAQ.

Fennec Pharmaceuticals Inc. (FENC)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$10.63+2.61%Close

SELLRECOVERY · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $369M
Beta: 1.10
P/E (TTM): -79.62

Short % float: 3.24%
Days to cover: 2.1
SI change: +4.7%

1W: +2.90%
1M: -8.76%

vs SPY 1W: +1.35%
vs SPY 1M: -10.52%

Industry peers

FMP comparable companies · ranked by market cap

AVTXSELLAvalo Therapeutics, Inc.$706MCRISISQ -10$13.43-1.10%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news